Clinical Trials Directory

Trials / Conditions / Tumor Infiltrating Lymphocytes

Tumor Infiltrating Lymphocytes

8 registered clinical trials studyying Tumor Infiltrating Lymphocytes — 5 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study of GC203 TIL in PDCA (RJ)
NCT06828328
Shanghai Juncell TherapeuticsEARLY_Phase 1
RecruitingStudy on the Safety and Tolerability of PD-1 Knockout Tumor-infiltrating T Cells (TILs) in the Treatment of Ad
NCT07035002
Ruijin HospitalPhase 1
CompletedA Study of GC101 TIL in Advanced Melanoma (BZ)
NCT06120712
Shanghai Juncell TherapeuticsPhase 1 / Phase 2
RecruitingA Study of TIL in Advanced Solid Tumors (DFGD)
NCT06488950
Shanghai Juncell TherapeuticsEARLY_Phase 1
CompletedA Phase I Study of GC101 TIL in Advanced Solid Tumors
NCT05417750
Shanghai Juncell TherapeuticsPhase 1
Not Yet RecruitingEfficacy and Safety of TILs in Treatment of Patients With Advanced or Metastatic Refractory Gynecological Canc
NCT05152797
Women's Hospital School Of Medicine Zhejiang UniversityPhase 1 / Phase 2
RecruitingA Clinical Study on TIL for the Treatment of Advanced Solid Tumors
NCT05087745
Shanghai Juncell TherapeuticsEARLY_Phase 1
UnknownTumor-Infiltrating Lymphocytes and Programmed Cell Death - Ligand 1 in Breast Cancer
NCT05250336
Sanjay Gandhi Postgraduate Institute of Medical Sciences—